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Abstract: Ancestral haplotypes are conserved but extremely polymorphic kilobase sequences, 
which have been faithfully inherited over at least hundreds of generations in spite of migration and 
admixture. They carry susceptibility and resistance to diverse diseases, including deficiencies of 
CYP21 hydroxylase (47.1) and complement components (18.1), as well as numerous autoimmune 
diseases (8.1). The haplotypes are detected by segregation within ethnic groups rather than by SNPs 
and GWAS. Susceptibility to some other diseases is carried by specific alleles shared by multiple 
ancestral haplotypes, e.g., ankylosing spondylitis and narcolepsy. The difference between these two 
types of association may explain the disappointment with many GWAS. Here we propose a 
pathway for combining the two different approaches. SNP typing is most useful after the conserved 
ancestral haplotypes have been defined by other methods. 
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1. Introduction 
It has been very nearly 50 years since Terasaki, Brewerton, and their colleagues discovered the 
extraordinary association between ankylosing spondylitis (AS) and HLA B27 [1,2]. With a few caveats 
of great interest to clinicians, all patients with AS have this allele, justifying the idea that B27 is an 
essential requirement for the disease–effectively a sine qua non [3]. However, the allele is much more 
frequent than the disease, and is therefore not itself sufficient. Penetrance is low [4,5]. Other known 
requirements are male sex and adult age, indicating that the mechanisms of susceptibility and 
pathogenesis may be quite complex and difficult to unravel. This is still the case today, although the 
fundamental finding has been confirmed to exhaustion [6]. 
It has been nearly 40 years since it was established that other HLA associations are completely 
different [3,7]. For example, in Caucasoids, the more severe forms of systemic lupus erythematosus 
(SLE) and myasthenia gravis with thymic hyperplasia (MG) are associated with the 8.1 ancestral 
haplotype [8,9]. This sequence includes B8, but extends over more than a megabase from HLA A to 
HLA DP. The genetic factors responsible for susceptibility and severity must be numerous and 
widely spaced throughout the MHC, although most evidence implicates the central MHC, including 
the C2, Bf, C4, HSP, and TNF genes, together with their associated non-coding or regulatory 
sequences. In contrast to AS, female sex is important for these conditions. [10]. 
By 1983, these two different types of association were well recognized [8]. Over subsequent 
decades, many more examples have been added. Narcolepsy is another example of the allelic form 
in that the DQB1 0602 association is not restricted to one ethnic group [11,12]. Therefore, explanations 
for a direct role of a single allele are sought, in this case, and may ultimately appear to be disarmingly 
simple as for haemochromatosis [13,14] and some drug hypersensitivities [15]. 
Cells 2019, 8, 944 2 of 10 
 
Deficiencies of C4, C2, and 21-hydroxylase (21OH) are examples of associations with extensive 
ancestral haplotypes (8.1, 18.1, and 47.1, respectively) [16,17]. In each case, there is a plausible 
explanation, in that the particular sequence includes a missing or defective gene. The observations 
by Alper et al. [7,18,19] were important in leading to concepts of conserved population haplotypes, 
which have been faithfully inherited over thousands of generations and are best illustrated by 57.1, 
which is represented to various degrees in multiple ethnicities. 
As different ancestral groups formed and migrated out of Africa and beyond, they carried 
conserved MHC sequences, which were fixed at each of the alpha, beta, gamma, and delta 
polymorphic frozen blocks (PFB) (see Figure 1 and Table 1). These sequences were shuffled laterally 
somewhat as populations mixed, and new combinations appeared, but the more polymorphic 
regions survive to this day [20–22]. In the case of these deficiencies, the defective or missing C4, C2, 
or 21OH genes remain within the frozen sequence. 
 
Figure 1. Polymorphic frozen blocks (PFB) in the MHC. Reproduced with permission from [5], and 
adapted from [16]. 
The organization of the MHC provides a model for the genome. Each ancestral haplotype has 
its own map. Polymorphic frozen blocks are shaded. Not all genes are shown. PerB11 is now 
designated MIC. Frozen refers to the freezing of the sequence by inhibition of recombination and 
mutations, whether 
1. unequal crossing-over, 
2. double recombination, 
3. nucleotide replacement, 
4. insertions and deletions, 
5. duplication, 
6. other. 
It was only through extensive family studies that it became clear that recombination occurred 
outside polymorphic frozen blocks (Figure 2). Indeed, the frozen blocks must have been inherited 
faithfully over many generations, since identical haplotypes occur in subjects with extensive family 
trees showing no known relationship, and even in populations that were widely scattered 
geographically, implying only very remote common ancestry. 
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Figure 2. Stable segregation of ancestral haplotypes through three generation family trees. The left 
describes the inheritance pattern, where the loci are bi-allelic and segregate independently. The right 
describes the inheritance pattern within PFB, where the alleles are highly polymorphic and the four 
ancestral haplotypes have segregated predictably. 
The reality is that the frozen blocks occupy only a limited proportion of the whole MHC region 
of a megabase or more, and we have not been able, as suggested in Figure 1, to define hard boundaries 
between frozen blocks and areas subject to recombination. This difficulty leads us to conclude that 
there are degrees of freezing as well as specific hotspots. Carrington [23] has contributed by 
identifying some of the regions which do recombine, but we suspect that such regions are dependent 
on the genomic environment rather than distance. For example, B8, which is Caucasoid specific by 
any measure, occurs in non- caucasoids with MG but hardly otherwise [24]. This observation implies 
that lateral transfer between haplotypes of very different ancestry may lead to thawing as a 
consequence of differences in the cis, trans, and epistatic interactions. Using multiethnic mapping is 
powerful [25–27] as a way to find which components carry susceptibility. In other words, ancestral 
haplotypes are preserved in ethnicities, but eventually fall apart in multiracial combinations. 
Susceptibility to autoimmune diseases, such SLE, MG, and insulin-dependent diabetes mellitus 
(IDDM) must be similarly frozen [8,28–32]—although, to date, there is no mechanistic explanation 
for the susceptibility [20,32]. Largely, for this reason, we have suggested a dominant role for non-
coding regulatory sequences associated with duplicons, indels, and retroviral-like elements (Table 1). 
We also implicate epistatic, trans, and cis interactions, with their potential to increase the degree of 
functional polymorphism exponentially [5,16]. Epistatic refers to sequences on different 
chromosomes, which segregate independently. Trans refers to the sequence of the second alternative 
chromosome. Cis refers to the same chromosome. 
Table 1. Lessons from MHC genomics. 
• Human diversity is inherited from ancestors, rather than created by recent mutation. 
• Diversity is regenerated at speciation and maintained by meiotic recombination between the ancestral 
haplotypes within polymorphic frozen blocks. 
• The unit of inheritance is the ancestral haplotype. 
• Such sequences carry specific alleles, duplicons, indels and retroviral-like elements (RLEs), which 
together regulate gene expression. 
Reproduced with permission from [5]. 
These lessons could not have been predicted from the prevailing concepts, which still underlie 
the thinking behind SNPs and GWAS (Table 2). This SNP-based thinking promotes an overemphasis 
on the role of ongoing mutation, compared to conservation of ancient polymorphism[33]. 
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Table 2. Alternative dogma. 
• Genetic diversity or inherited variation requires ongoing mutation. 
• Diversity accumulates through errors in the copying of DNA. 
• The unit of inheritance is the allele. 
• At each locus alleles may be deleterious, beneficial, or neutral. 
• Meiotic recombination scrambles maternal and paternal alleles. 
• Linkage disequilibrium between SNPs defines haplotypes. 
Reproduced with permission from [5]. 
Clearly, any understanding of MHC genomics leading to disease must take account of the 
pragmatic observations implicating age- and sex-dependent penetrance. In Figure 3, we illustrate the 
potential importance of cis and trans interactions by proposing that ancestral haplotypes can be 
represented by meshing polymorphic cogs. The degree of meshing or interaction, whether cis or 
trans, is affected by size and density (expression), as well as by competition with similar cogs, 
including those representing paralogous sequences encoded on other chromosomes. Thus, MHC, 
genotypically identical subjects may be affected to different degrees (Figure 3). 
 
Figure 3. Segregating ancestral haplotypes preserve cis interactions. Ancestral haplotypes are 
represented by two cogs meshing vertically (in cis). The size and shape of cogs represent 
polymorphism or variant forms of the blocks. For example, the father has yellow–blue (a) and red–
orange (b) haplotypes while the mother has green-cyan (c) and orange-brown (d) haplotypes. 
Haplotype (a) has been transmitted to the eldest daughter, eldest son, and youngest son. The middle 
two children have inherited haplotype (b). Reactive meshing is dependent on hormonal and other 
environmental influences. The oldest and youngest offspring are genotypically identical, but the 
interactions are different as a consequence of the sexual environment. Adapted with permission from 
[5]. 
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These models have led to the concept of multifunctional polymorphic control of metabolic and 
other pathways. Cascades involving stepwise activation of related products, such as the complement 
system, are promising targets for further study. 
2. Recognition of Conserved Ancestral Haplotypes 
Table 3 illustrates how ancestral haplotypes were recognized initially. Today there are many 
more haplotypic markers, including noncoding sequences between the loci shown. As the number of 
haplotypic markers increased, including SNPs, it became more and more obvious that very few are 
haplo-specific. It follows that linkage disequilibrium (LD) cannot define such haplotypes. For 
example, 2 × 2 delta values cannot identify 18.1 and 18.2, because the alleles are shared by other 
haplotypes. 
Table 3. Haplotype definitions and frequencies in an Australian population. 
Ancestral Haplotype A Cw B C2 Bf C4A C4B DR DQ Frequency 
7.1 3 7 7 C S 3 1 2 6 12.9% 
8.1 1 7 8 C S 0 1 3 2 13.2% 
13.1   13  S 3 1 7  2.6% 
18.1 25 - 18 0 S 4 2 3 6 1.1% 
18.2 30 5 18 C F1 3 0 3 2 1.7% 
18.3   18  S 3 1 5  5.2% 
35.1  4 35  S 3 1 5  6.9% 
35.2 3 4 35 C F 3 + 2 0 1 5 0.9% 
35.3 11 4 35  S 3 0 1 5 2.3% 
44.1 2 5 44 C S 3 0 4 7 5.5% 
44.2 29 4 44 C F 3 1 7 2 2.6% 
47.1 3 6 47 C F 1 0 7 2 <0.6%  
57.1 1 6 57 C S 6 1 7 9 2.6% 
65.1  8 65 C S 2 1 + 2 1 5 0.6% 
Adapted from [34] and [35]. 
3. Genome-Wide Association Studies and Single Nucleotide Polymorphisms 
We believe that the above concepts and models of ancestral haplotypes suggest an alternative 
approach to the conduct and analysis for genome-wide association studies. When applied to the 
MHC, some results of commercial SNP typing have been disappointing, even to the point that a 
recent review by Kennedy et al. [36] essentially dismisses the many classic studies, and very unwisely 
blames “HLA typing errors, disregard of population structure and lack of replication” [36]. The same 
authors cite a paper which promotes a “focus on haplotypes … first suggested in 1987”, thereby 
ignoring important previous contributions on haplotypes—including the original use of the term in 
1967 by Ruggero Ceppellini [37,38]—and a huge body of careful observations that have been 
confirmed repeatedly and rediscovered, without attribution, in the past few decades. 
The International Hapmap Project [39–41] is a potentially valuable resource of high-resolution 
SNP-typed individuals, and includes samples of cell lines used to define the genomic sequence of 
conserved, extended ancestral haplotypes, which segregate faithfully through families. Surprisingly, 
the proponents and users [42] of Hapmap have ignored the opportunities for reconciliation with 
earlier studies, which addressed the shortcomings of LD analysis and focused on haplotypic 
sequences, including RLEs; indels; duplications; and single nucleotide polymorphism in the literal 
sense, used by Gaudieri et al. [43] and Longman et al. [44] to map regions of extensive, interrupted 
sequence differences. The importance of PFB [16] or fixity [45] was also ignored until rediscovered 
[46]. 
A more balanced review by Petersdorf and O’hUigin [47] begins the daunting process of 
integrating population genetics, classic HLA associations, ancestral haplotypes, polymorphic frozen 
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blocks, SNP typing, and gene expression [47]. The authors hope for “the study of haplotype-
associated phenotypic differences” and for “haplotype-matching” in transplantation. Indeed, there 
is already great encouragement for each of these ambitions. The functional differences conferred by 
ancestral haplotypes, such as 8.1, have been well known for more than 30 years, and include TNF and 
IgA concentrations, even though the latter is not encoded within the MHC [16,48,49]. The benefit of 
haplotype matching in renal and bone marrow transplantation was established decades ago [50,51]. 
4. Reconciling MHC Genomics and SNP Typing 
While we recognize that the disconnect between classical MHC and later SNP genomics will 
decrease [47,52], we hope this happens quickly. To this end, we summarize the issues as follows: 
1. There is no possibility of a single reference sequence. Rather, there are numerous ancestral 
haplotypes, each with its own very extensive and specific sequence [35,53–55]. 
2. These sequences are characteristic of ancestral populations or ethnicities. SNP typing on 
heterozygous mixed populations cannot reveal ancestral haplotype—or at least, must be 
extremely inefficient [20]. 
3. MHC complexity is best managed by defining haplotypes through segregation in extensive 
family studies [56]—not trios—since the power of segregation increases with the number of 
copies in different heterozygous combinations. Recombination can be demonstrated given 
sufficient generations to study. 
4. Ancestral haplotypes include specific duplications, indels, etc. [54]. Fortunately, there are now 
many panels of homozygous cell lines and libraries of their sequences available [57,58]. These 
should be the references and should replace allele and SNP databases. 
5. Penetrance is crucial but complex, and depends on age, sex, and a multitude of environmental 
factors that will vary from time to time and in different settings [53]. Cis and trans interactions 
are well known contributors to susceptibility and severity [5] These need to be included in the 
experimental design, but will be difficult to understand until the relevant pathways are defined. 
We recommend careful consideration of the concept of whole genome duplications resulting in 
paralogous sequences [16,59], which may compete with and modify the effect of any sequence 
implicated through SNP analysis. 
6. Linkage disequilibrium (LD) is an incomplete reflection of conserved haplotypes and their 
relative frequencies. Many highly conserved haplotypes cannot be detected by delta values, 
because even though haplotypic (i.e., present on all examples), individual SNPs are not haplo-
specific. Different haplotypes share nucleotides and alleles at different locations and relative 
frequencies. LD between SNPs is misleading if used to define functional haplotypes. 
Haplospecific recombination creates further complexity [23,60,61]. 
7. There are at least two types of association with disease, as described above. No doubt, there will 
be further categories, especially as cis and trans interactions are defined. IDDM is an example of 
the need to address the mode of inheritance and multiple interactions, as described by Alper et 
al. [62,63]. Epistatic interactions may also be important. 
8. The low positive predictive values of a genetic marker for a disease will remain so until the 
pathogenic pathways are understood. Fortunately, for clinical purposes, there are examples 
where the absence of an allele or sequence can be useful for the exclusion of a diagnosis. 
However, the presence of the same allele does not permit confirmation of the diagnosis—take, 
for example, HLA B27 [4]. Thus, those designing future studies should consider how the results 
will be of practical value, and at the same time, be useful in defining the biology. 
9. Many regions of biological and statistical importance are not included in commercial SNP 
typing. In fact, duplications, indels, RLEs, and ambiguities may be very informative [16]. 
10. The MHC is a useful model for other genomic regions with polymorphic frozen blocks [64]. 
11. An understanding of synteny and paralogy is very valuable [65]. 
12. Many MHC associations, such as narcolepsy, 21-OH deficiency, and haemochromatosis are not 
immunologically mediated. There is no justification for prejudice in interpreting results. Current 
limited understanding of pathological processes may lead to confusion. In fact, as illustrated by 
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the value of informative clinic-to-laboratory studies, there is potential to elucidate these 
processes. 
13. A promising approach includes understanding the processes and genetics responsible for 
autoimmune diseases induced by immune checkpoint inhibitors, vaccines, and drugs, such as 
D-Penicillamine. The value of genomics increases when the inducing agent is known [15]. 
5. Conclusions 
One lesson might be that there are incompatible concepts and terminology, as well as a very 
patchy understanding of the incontrovertible facts of MHC associations and structure. Another might 
be that research is constrained by the limitations of commercial platforms. 
We hope our commentary is helpful in providing background for new discoveries. Hence the 
subtitle: “Looking Back to Go Forward”. Surely, it is important not to dismiss the history as “HLA 
typing errors”. In fact, the International HLA workshops provide a useful resource for haplotype 
association with disease, as well as for matching donors and hosts for transplantation. 
SNP typing is most useful after the conserved ancestral haplotypes have been defined by other 
methods. 
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